These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Immunological indices of patients with destructive pulmonary tuberculosis due to bovine and human Mycobacterium tuberculosis]. Naubet'iarova AN; Syzdykova NS; Alenova AKh Probl Tuberk; 1987; (4):34-6. PubMed ID: 3110764 [No Abstract] [Full Text] [Related]
7. [Immunological studies in the treatment of tuberculosis with flureniside]. Sibirnaia RI Probl Tuberk; 1997; (5):27-8. PubMed ID: 9454246 [TBL] [Abstract][Full Text] [Related]
8. [Prevention of side effects of specific chemotherapy in patients with pulmonary tuberculosis]. Batian AN; Abramovskaia AK; Batian ON Probl Tuberk; 1991; (7):60-2. PubMed ID: 1754594 [TBL] [Abstract][Full Text] [Related]
9. Effects of chemotherapy on the immunological characteristics of patients with primary destructive pulmonary tuberculosis. Khomenko AG; Averbach MM; Litvinov VI; Gergert VJ; Chukanov VI Bull World Health Organ; 1984; 62(5):763-71. PubMed ID: 6391716 [TBL] [Abstract][Full Text] [Related]
10. [Immunological status of newly detected patients with destructive pulmonary tuberculosis]. Khomenko AG; Averbakh MM; Rudoĭ NM; Litvinov VI; Gergert VIa Probl Tuberk; 1979 Apr; (4):13-7. PubMed ID: 312495 [No Abstract] [Full Text] [Related]
11. [Clinico-immunological criteria of the effectiveness of chemotherapy in patients with destructive pulmonary tuberculosis]. Ivaniuta OM; Kogosova LS; Il'nitskiĭ IG; Zamdborg IuL; Davyda RS Probl Tuberk; 1986; (2):42-5. PubMed ID: 3703842 [No Abstract] [Full Text] [Related]
12. [T- and b systems of immunity in patients with newly detected destructive pulmonary tuberculosis during complex therapy]. Kogosova LS; Bal'tseva LV; Petrashenko AI Probl Tuberk; 1981 Feb; (2):24-8. PubMed ID: 6972527 [No Abstract] [Full Text] [Related]
13. [Problems of the optimal duration of chemotherapy in newly detected destructive pulmonary tuberculosis]. Doroshenkova AE; Avtandilov GG Probl Tuberk; 1981 Jan; (1):58-61. PubMed ID: 7208468 [No Abstract] [Full Text] [Related]
15. [The use of thymalin in the combined chemotherapy of patients with infiltrative destructive pulmonary tuberculosis]. Ivanova LA Vrach Delo; 1989 Oct; (10):57-9. PubMed ID: 2617987 [TBL] [Abstract][Full Text] [Related]
16. [Specific features of cellular immunity of pulmonary tuberculosis in patients with diabetes mellitus]. Karachunskiĭ MA; Gergert VIa; Iakovleva OB Probl Tuberk; 1997; (6):59-60. PubMed ID: 9503939 [TBL] [Abstract][Full Text] [Related]
19. [Laser and chemotherapy and the immune status of patients with fibrous-cavernous tuberculosis]. Sergeeva LV; Dobkin VG; Markov AN Probl Tuberk; 1996; (1):22-4. PubMed ID: 8907479 [TBL] [Abstract][Full Text] [Related]
20. [Effectiveness of different chemotherapy regimens in newly detected patients with destructive pulmonary tuberculosis]. Omarov TO; Shefer LB; V'iushkova SV; Abzharkenova ESh Probl Tuberk; 1987; (4):15-7. PubMed ID: 3601919 [No Abstract] [Full Text] [Related] [Next] [New Search]